How Simmering turns healthcare data into better care

Wednesday, September 9, 2026
Jacob Simmering, PhD, uses large healthcare datasets to better understand that process and opportunities for early care.

Integrated care model improves hepatitis C treatment access for people with substance use disorder

Friday, September 4, 2026
A new study co-authored Andrea Weber, MD, who holds dual appointments in Internal Medicine and Psychiatry, found that bringing hepatitis C treatment directly into an addiction medicine clinic significantly increased the number of patients who started therapy.

Bowen to examine the impact of rurality on outcomes in cystic fibrosis-related diabetes

Tuesday, September 1, 2026
Elizabeth Bowen, MD, clinical assistant professor in Endocrinology and Metabolism, has received a three-year, $193,060 career development and training grant from the Cystic Fibrosis Foundation (CFF).

VHA National Telehospitalist Program renewed with three-year funding

Monday, August 31, 2026
What started as a pilot serving a rural Department of Veterans Affairs (VA) hospital in Wisconsin has expanded to 15 more sites across 11 states and covering up to 400 beds at any given day

Imai discovers protein’s role in insulin secretion

Tuesday, August 25, 2026
A study led by Yumi Imai, MD, Professor in Endocrinology and Metabolism, has identified a protein that helps pancreatic beta cells respond to glucose and release insulin.

New framework offers closer look at patterns in hospital antibiotic use

Monday, August 17, 2026
Researchers from the University of Iowa and Iowa City Veterans Affairs Health Care System have developed a new way to look more closely at how hospitals prescribe antibiotics. And, importantly, what may be driving differences in antibiotic use between hospitals.

Shlossman investigates inflammation in cystic fibrosis

Monday, August 10, 2026
Michael Shlossman, MD, a third-year fellow in our pulmonary disease and critical care medicine program, has received a two-year Clinical Fellowship Research Award from the Cystic Fibrosis Foundation.

Gerke, Pezzulo awarded five-year, $3.8M R01

Monday, August 3, 2026
Alicia Gerke, MD, MBA, and Alejandro A. Pezzulo, MD, have secured a grant from the National Heart, Lung, and Blood Institute (NHLBI) to investigate environmental exposures that drive sarcoidosis.

New machine learning model personalizes antibiotic selection

Wednesday, July 29, 2026
Researchers at the University of Iowa hope a new machine learning model can predict antibiotic resistance using information already available in a patient’s electronic health record.

From screening to support: UI study looks at health coaching for inactive patients

Friday, July 24, 2026
A 12-week behavioral counseling intervention helped patients with cardiovascular disease risk factors improve several health behaviors and outcomes.